NASDAQ : BCAB

BioAtla, Inc. — Earnings Estimates

$3.46 USD

$0.13 (3.9%)

Volume
36.74K
Average Volume
48.92K
Market Capitalization
$5.74M
P/E Ratio
-0.08
Dividend Yield
0.00%
Price Target
$250.00
Year High
$71.50
Year Low
$3.12
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.15

Annual earnings financials

BCAB financial data with annual/quarterly toggle

BCAB GAAP EPS - Annual & Quarterly

BCAB Sales Revenue - Annual & Quarterly

BCAB Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

BCAB Estimated and Actual Revenue by Quarter
BCAB Estimated and Actual EPS by Quarter
BCAB Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
2026-06-30 0 - - - - - -
2026-03-31 0 - - - - - -
2025-12-31 4 -140K -140K -140K -140K -140K -140K
2023-12-31 2 -3M -3M -3M -3M -3M -3M
BCAB Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 0 -10.51M -10.51M -10.51M - - -
2026-09-30 0 -10.51M -10.51M -10.51M - - -
2026-06-30 0 -12.76M -12.76M -12.76M - - -
2026-03-31 0 -15.02M -15.02M -15.02M - - -
2025-12-31 4 -18.02M -18.02M -18.02M 23.31M 23.31M 23.31M
2023-12-31 2 -64.75M -49.88M -59.5M 499.4M 499.4M 499.4M
BCAB Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 0 - - - 1 -7 -7 -7
2026-09-30 0 - - - 1 -7 -7 -7
2026-06-30 0 - - - 1 -8.5 -8.5 -8.5
2026-03-31 0 - - - 1 -10 -10 -10
2025-12-31 4 700K 700K 700K 1 -12 -12 -12
2023-12-31 2 15M 15M 15M 3 -43.12132 -33.21507 -39.625